What we know

The Prima implant is a new device designed to restore some vision in patients with advanced age-related macular degeneration (AMD), specifically those suffering from geographic atrophy, a form where retinal cells die off. This implant aims to partially recover sight by bypassing damaged retinal cells. While early reports highlight its potential benefits, there is limited information on widespread clinical use or independent verification of its effectiveness.

Why it matters

Age-related macular degeneration is a major cause of vision loss worldwide, especially among older adults. Geographic atrophy, an advanced stage of AMD, leads to permanent blindness due to the death of retinal cells. Restoring vision in these patients has been a significant challenge.

What is still unknown

No independent tests have confirmed the accuracy or effectiveness of the Prima implant. Details about supported languages, broader availability, and a general release timeline have not been disclosed.